Description
SNS-032.HCL is a novel cyclin-dependent kinase inhibitor, which exhibits potent and selective inhibitory activity against Cdk2, Cdk7, and Cdk9. It effectively kills chronic lymphocytic leukemia cells in vitro regardless of prognostic indicators and treatment.
Product Overview
cyclin-dependent kinase inhibitor
Stability
2 years -20 centigrade Powder
1 month -4 centigrade in DMSO
More than one month -80 centigrade in DMSO
Molecular Formula
C17H24N4O2S2.HCl
Chemical Name
N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)piperidine-4-carboxamide hydrochloride
Solubility
DMSO > 112mg/mL Water >1mg/mL Ethanol > 4mg/mL